SC Filed 2020-10-09 Event — SEC 0000921895-20-002578 →

BIOTECHNOLOGY VALUE FUND L P → XOMA Corp XOMAP

Stake: — Shares: —

Composite Decision Signal · PASS (LOW BASE-RATE EDGE) Conviction Score: 5/100 · Filer 90d Win Rate: 33% · Hist. 90d Edge: +0.9%

Filer track record (6 filings): 33% 90d win rate, +0.9% 90d edge

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

76 transactions

0 buys · 61 sales · 0 awards/exercises

Issuer Cluster

11 13D/G filings on this issuer

10 other filings besides this one

Filer Track Record

45 filings by this filer

44 other filings in the data moat

Short Interest · settle 2026-06-30

DTC 1.00

276 shares short · -50.4% vs prior

Form 4 Insider Transactions · last 365d

Date	Insider	Role	Type	Shares	Price	Value
2026-07-14	PERRY MATTHEW D	director	J	24,138	—	—
2026-07-14	Montano Maricel Perea	officer	J	42,306	—	—
2026-07-14	Montano Maricel Perea	officer	J	65	—	—
2026-07-14	Montano Maricel Perea	officer	Disposition	37,074	—	—
2026-07-14	Montano Maricel Perea	officer	Disposition	11,316	—	—
2026-07-14	LIMBER JOSEPH M	director	J	9,532	—	—
2026-07-14	LIMBER JOSEPH M	director	Disposition	10,000	—	—
2026-07-14	LIMBER JOSEPH M	director	Disposition	20,000	—	—
2026-07-14	LIMBER JOSEPH M	director	Disposition	8,000	$4.03	$32K
2026-07-14	LIMBER JOSEPH M	director	Disposition	2,366	$19.40	$46K
2026-07-14	LIMBER JOSEPH M	director	Disposition	5,052	$25.16	$127K
2026-07-14	LIMBER JOSEPH M	director	Disposition	8,167	$15.59	$127K
2026-07-14	LIMBER JOSEPH M	director	Disposition	6,152	$21.27	$131K
2026-07-14	LIMBER JOSEPH M	director	Disposition	5,101	$31.04	$158K
2026-07-14	LIMBER JOSEPH M	director	Disposition	8,996	$17.86	$161K
2026-07-14	LIMBER JOSEPH M	director	Disposition	10,967	$21.39	$235K
2026-07-14	LIMBER JOSEPH M	director	Disposition	9,763	$24.71	$241K
2026-07-14	LIMBER JOSEPH M	director	Disposition	9,936	$25.12	$250K
2026-07-14	Kosacz Barbara	director	J	6,269	—	—
2026-07-14	Kosacz Barbara	director	Disposition	19,979	$12.65	$253K
2026-07-14	Kosacz Barbara	director	Disposition	8,167	$15.59	$127K
2026-07-14	Kosacz Barbara	director	Disposition	6,152	$21.27	$131K
2026-07-14	Kosacz Barbara	director	Disposition	5,101	$31.04	$158K
2026-07-14	Kosacz Barbara	director	Disposition	8,996	$17.86	$161K
2026-07-14	Kosacz Barbara	director	Disposition	10,967	$21.39	$235K

Showing 25 of 76

Other 13D/G Filings on XOMA Corp

Filed	Form	Filer	Stake	Shares
2026-07-16	SCHEDULE 13D/A	BIOTECHNOLOGY VALUE FUND L P	—	0	view →
2026-05-18	SCHEDULE 13D/A	BIOTECHNOLOGY VALUE FUND L P	—	3,635,758	view →
2026-05-01	SCHEDULE 13D	LIGAND PHARMACEUTICALS INC	47.00%	8,062,678	view →
2025-05-20	SCHEDULE	BIOTECHNOLOGY VALUE FUND L P	21.60%	2,590,303	view →
2025-01-28	SCHEDULE	BIOTECHNOLOGY VALUE FUND L P	25.30%	2,983,026	view →
2021-04-02	SC	BIOTECHNOLOGY VALUE FUND L P	—	—	view →
2020-12-15	SC	BIOTECHNOLOGY VALUE FUND L P	—	—	view →
2020-09-23	SC	BIOTECHNOLOGY VALUE FUND L P	—	—	view →
2020-03-18	SC	BIOTECHNOLOGY VALUE FUND L P	—	—	view →
2019-12-23	SC	BIOTECHNOLOGY VALUE FUND L P	—	—	view →

Other Filings by BIOTECHNOLOGY VALUE FUND L P

Filed	Form	Issuer	Stake	Shares
2026-10-21	SCHEDULE 13G	Frazier Life Sciences Acquisition Corp. II	—	—	view →
2026-10-16	SCHEDULE 13D/A	Olema Pharmaceuticals, Inc.	9.80%	5,946,981	view →
2026-09-21	SCHEDULE 13G	Tyra Biosciences, Inc.	—	—	view →
2026-09-18	SCHEDULE 13G	Alector, Inc.	—	—	view →
2026-08-04	SCHEDULE 13D	Entera Bio Ltd.	9.99%	9,171,741	view →
2026-07-20	SCHEDULE 13G	Research Alliance Corp IV	—	—	view →
2026-07-16	SCHEDULE 13D/A	XOMA Royalty Corp	—	0	view →
2026-07-10	SCHEDULE 13G	Pyxis Oncology, Inc. PYXS	—	—	view →
2026-06-29	SCHEDULE 13D/A	MoonLake Immunotherapeutics MLTX	19.70%	8,302,735	view →
2026-06-26	SCHEDULE 13D/A	Kymera Therapeutics, Inc. KYMR	6.30%	2,712,852	view →
2026-06-04	SCHEDULE 13G	Q32 Bio Inc. QTTB	—	—	view →
2026-05-29	SCHEDULE 13G	Research Alliance Corp III RACC	—	—	view →
2026-05-27	SCHEDULE 13G	OnKure Therapeutics, Inc. OKUR	—	—	view →
2026-05-18	SCHEDULE 13D/A	XOMA Royalty Corp XOMAP	—	3,635,758	view →
2026-04-02	SCHEDULE 13D/A	MoonLake Immunotherapeutics MLTX	22.30%	8,302,735	view →
2025-11-24	SCHEDULE	Repare Therapeutics Inc.	24.00%	10,333,600	view →
2025-05-20	SCHEDULE	XOMA Royalty Corp XOMAP	21.60%	2,590,303	view →
2025-01-28	SCHEDULE	XOMA Royalty Corp XOMAP	25.30%	2,983,026	view →
2024-10-08	SC	MoonLake Immunotherapeutics MLTX	—	—	view →
2024-07-19	SC	Inventiva S.A. IVEVF	—	—	view →

Showing 20 of 44

Want this depth on every filing the moment it hits SEC EDGAR?

Free $0 (48h-delayed alerts) · Individual $49/mo (real-time) · Team & API $199/mo · Enterprise.

See pricing →